|
MGNX
|
MacroGenics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
KPTI
|
Karyopharm Therapeutics Inc.
|
0.03%
|
US
|
NASDAQ
|
|
KNTE
|
Kinnate Biopharma Inc.
|
0.03%
|
US
|
NASDAQ
|
|
IMAB
|
I-Mab
|
0.03%
|
US
|
NASDAQ
|
|
GRTS
|
Gritstone Oncology, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
CNCE
|
Concert Pharmaceuticals, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
CDXS
|
Codexis, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
ATRA
|
Atara Biotherapeutics, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
ATAI
|
ATAI Life Sciences N.V.
|
0.03%
|
US
|
NASDAQ
|
|
ALPN
|
Alpine Immune Sciences, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
ADAP
|
Adaptimmune Therapeutics plc
|
0.03%
|
US
|
NASDAQ
|
|
ACET
|
Adicet Bio, Inc.
|
0.03%
|
US
|
NASDAQ
|
|
URGN
|
UroGen Pharma Ltd.
|
0.02%
|
US
|
NASDAQ
|
|
SELB
|
Selecta Biosciences, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
OPTN
|
OptiNose, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
OMER
|
Omeros Corporation
|
0.02%
|
US
|
NASDAQ
|
|
MRNS
|
Marinus Pharmaceuticals, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
GTHX
|
G1 Therapeutics, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
GOSS
|
Gossamer Bio, Inc.
|
0.02%
|
US
|
NASDAQ
|
|
CNTA
|
Centessa Pharmaceuticals plc
|
0.02%
|
US
|
NASDAQ
|